Repro Med Systems
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $12,045 | $11,764 | $10,895 | $10,402 |
Gross Profit | 7,846 | 7,033 | 6,817 | 6,264 |
EBITDA | 468 | -609 | -302 | -573 |
EBIT | 258 | -807 | -482 | -778 |
Net Income | 252 | -807 | -486 | -777 |
Net Change In Cash | 12,045 | 11,764 | 10,895 | 10,402 |
Free Cash Flow | -361 | -75 | 686 | 12 |
Cash | 8,287 | 8,767 | 8,872 | 8,464 |
Basic Shares | 49,509 | 46,364 | 46,187 | 46,238 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $41,127 | $33,646 | $28,517 | $27,896 |
Gross Profit | 25,604 | 21,331 | 16,708 | 15,368 |
EBITDA | -1,805 | -5,175 | -8,903 | -10,088 |
EBIT | -2,616 | -6,063 | -9,773 | -10,675 |
Net Income | -2,637 | -6,066 | -13,741 | -8,661 |
Net Change In Cash | 41,127 | 33,646 | 28,517 | 27,896 |
Cost of Revenue | -7,926 | |||
Free Cash Flow | -470 | -1,617 | -5,707 | -8,206 |
Cash | 8,872 | 9,580 | 11,482 | 17,408 |
Basic Shares | 46,187 | 45,803 | 45,601 | 45,002 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | $0.01 |
2026-03-31 | -$0.01 |
2025-12-31 | $0.01 |
2025-09-30 | -$0.01 |